Ke Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ke Yan has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Le Lu
DAMO Academy Alibaba Group
7 shared publicationsXiaoli Yin
Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China
5 shared publications- Yu Shi
Department of Radiology, Shengjing Hospital of China Medical University, Shenyang, China
5 shared publications Yuan Gao
DAMO Academy, Alibaba Group, Hangzhou, China
5 shared publicationsChunli Li
Shengjing Hospital of China Medical University
4 shared publicationsLing Zhang
DAMO Academy, Alibaba Group
4 shared publications
Latest Publications
- 19 August 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (10) , 3717-3729
Large-scale AI-guided liver malignancy diagnosis: multicenter study and a single-arm trial
Liver malignancies are frequently evaluated on contrast-enhanced computed tomography (CE-CT), but missed or delayed diagnoses remain a clinically important challenge in high-volume, real-world radiology workflows, highlighting the need for scalable diagnostic safety net approaches. To address this, we developed the Liver DiagnOsis Network (LiON), a CE-CT-based artificial intelligence (AI) system that supports flexible multiphase processing, clinical data integration and workflow-compatible liver malignancy diagnosis. LiON was trained on 6,443 patients and retrospectively validated across 22,251 patients from multicenter and real-world cohorts. LiON achieved high performance for malignancy diagnosis, with an area under the receiver operating characteristic curve (AUC) of 0.975 (95% confidence interval (CI): 0.971−0.979), and maintained robust performance in real-world cohorts and among patients with hepatic steatosis (AUC 0.971, 95% CI: 0.952−0.985) and cirrhosis (AUC 0.924, 95% CI: 0.901−0.946). We then conducted a single-arm trial in 10,333 patients in routine clinical practice, in which LiON functioned as an additional AI reader within the existing clinical workflow. The trial met its primary endpoint, defined as an AUC for malignancy diagnosis with the lower bound of the 95% CI exceeding 0.900, achieving an AUC of 0.952 (95% CI: 0.942−0.961). Secondary outcomes demonstrated that AI−human collaboration identified 51 previously overlooked lesions (15 malignancies) and triggered 37 amended radiology reports, 22 multidisciplinary team escalations and clinical management changes in a subset of patients. These findings suggest that AI, when deployed as a workflow-compatible diagnostic support, may help reduce missed or delayed diagnoses and guide clinical interventions. Nevertheless, further evidence from prospective comparative studies across diverse healthcare systems is warranted to assess effects on clinical outcomes. ClinicalTrials.gov identifier: NCT07153783.
- 19 August 2026
- Published by Springer Nature in Nature Medicine
- Vol. 32 (10) , 3717-3729
Large-scale AI-guided liver malignancy diagnosis: multicenter study and a single-arm trial
Liver malignancies are frequently evaluated on contrast-enhanced computed tomography (CE-CT), but missed or delayed diagnoses remain a clinically important challenge in high-volume, real-world radiology workflows, highlighting the need for scalable diagnostic safety net approaches. To address this, we developed the Liver DiagnOsis Network (LiON), a CE-CT-based artificial intelligence (AI) system that supports flexible multiphase processing, clinical data integration and workflow-compatible liver malignancy diagnosis. LiON was trained on 6,443 patients and retrospectively validated across 22,251 patients from multicenter and real-world cohorts. LiON achieved high performance for malignancy diagnosis, with an area under the receiver operating characteristic curve (AUC) of 0.975 (95% confidence interval (CI): 0.971−0.979), and maintained robust performance in real-world cohorts and among patients with hepatic steatosis (AUC 0.971, 95% CI: 0.952−0.985) and cirrhosis (AUC 0.924, 95% CI: 0.901−0.946). We then conducted a single-arm trial in 10,333 patients in routine clinical practice, in which LiON functioned as an additional AI reader within the existing clinical workflow. The trial met its primary endpoint, defined as an AUC for malignancy diagnosis with the lower bound of the 95% CI exceeding 0.900, achieving an AUC of 0.952 (95% CI: 0.942−0.961). Secondary outcomes demonstrated that AI−human collaboration identified 51 previously overlooked lesions (15 malignancies) and triggered 37 amended radiology reports, 22 multidisciplinary team escalations and clinical management changes in a subset of patients. These findings suggest that AI, when deployed as a workflow-compatible diagnostic support, may help reduce missed or delayed diagnoses and guide clinical interventions. Nevertheless, further evidence from prospective comparative studies across diverse healthcare systems is warranted to assess effects on clinical outcomes. ClinicalTrials.gov identifier: NCT07153783.
- Top Cited PapersOpen Access
- 11 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 1562
Multi-modal AI for opportunistic screening, staging and progression risk stratification of steatotic liver disease
The global rise in steatotic liver disease poses a significant public health challenge. While non-contrast computed tomography scans hold promise for opportunistic detection of steatotic liver disease, their potential for staging and risk assessment remains underexplored. Here we present a multimodal AI model trained on a large dataset, comprising of (n=968) histopathologically and (n=1103) radiologically confirmed cases, validated against both histology (n=660) and MRI-PDFF (n=375) gold standards, demonstrating high accuracy in detecting mild to severe steatosis (AUC: 0.904-0.929) and clinically significant fibrosis (AUC: 0.824-0.888). Furthermore, integrating the model into the standard clinical pathway improves primary risk screening in a retrospective patient cohort (n=1192), identifying 36% more patients at risk of fibrosis progression. Using Cox proportional hazard model, we observe that the intermediate-high risk patients identified by the optimized clinical pathway exhibits a significantly higher incidence of cirrhosis (hazard ratio: 5.54: 2.69-11.42), showcasing the model's potential for early detection and management of steatotic liver disease.
- 11 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 1562
Top Cited PapersOpen AccessMulti-modal AI for opportunistic screening, staging and progression risk stratification of steatotic liver disease
The global rise in steatotic liver disease poses a significant public health challenge. While non-contrast computed tomography scans hold promise for opportunistic detection of steatotic liver disease, their potential for staging and risk assessment remains underexplored. Here we present a multimodal AI model trained on a large dataset, comprising of (n=968) histopathologically and (n=1103) radiologically confirmed cases, validated against both histology (n=660) and MRI-PDFF (n=375) gold standards, demonstrating high accuracy in detecting mild to severe steatosis (AUC: 0.904-0.929) and clinically significant fibrosis (AUC: 0.824-0.888). Furthermore, integrating the model into the standard clinical pathway improves primary risk screening in a retrospective patient cohort (n=1192), identifying 36% more patients at risk of fibrosis progression. Using Cox proportional hazard model, we observe that the intermediate-high risk patients identified by the optimized clinical pathway exhibits a significantly higher incidence of cirrhosis (hazard ratio: 5.54: 2.69-11.42), showcasing the model's potential for early detection and management of steatotic liver disease.
- Open Access
HarmonySeg: Tubular Structure Segmentation with Deep-Shallow Feature Fusion and Growth-Suppression Balanced Loss
Accurate segmentation of tubular structures in medical images, such as vessels and airway trees, is crucial for computer-aided diagnosis, radiotherapy, and surgical planning. However, significant challenges exist in algorithm design when faced with diverse sizes, complex topologies, and (often) incomplete data annotation of these structures. We address these difficulties by proposing a new tubular structure segmentation framework named HarmonySeg. First, we design a deep-to-shallow decoder network featuring flexible convolution blocks with varying receptive fields, which enables the model to effectively adapt to tubular structures of different scales. Second, to highlight potential anatomical regions and improve the recall of small tubular structures, we incorporate vesselness maps as auxiliary information. These maps are aligned with image features through a shallow-and-deep fusion module, which simultaneously eliminates unreasonable candidates to maintain high precision. Finally, we introduce a topology-preserving loss function that leverages contextual and shape priors to balance the growth and suppression of tubular structures, which also allows the model to handle low-quality and incomplete annotations. Extensive quantitative experiments are conducted on four public datasets. The results show that our model can accurately segment 2D and 3D tubular structures and outperform existing state-of-the-art methods. External validation on a private dataset also demonstrates good generalizability.
Open AccessHarmonySeg: Tubular Structure Segmentation with Deep-Shallow Feature Fusion and Growth-Suppression Balanced Loss
Accurate segmentation of tubular structures in medical images, such as vessels and airway trees, is crucial for computer-aided diagnosis, radiotherapy, and surgical planning. However, significant challenges exist in algorithm design when faced with diverse sizes, complex topologies, and (often) incomplete data annotation of these structures. We address these difficulties by proposing a new tubular structure segmentation framework named HarmonySeg. First, we design a deep-to-shallow decoder network featuring flexible convolution blocks with varying receptive fields, which enables the model to effectively adapt to tubular structures of different scales. Second, to highlight potential anatomical regions and improve the recall of small tubular structures, we incorporate vesselness maps as auxiliary information. These maps are aligned with image features through a shallow-and-deep fusion module, which simultaneously eliminates unreasonable candidates to maintain high precision. Finally, we introduce a topology-preserving loss function that leverages contextual and shape priors to balance the growth and suppression of tubular structures, which also allows the model to handle low-quality and incomplete annotations. Extensive quantitative experiments are conducted on four public datasets. The results show that our model can accurately segment 2D and 3D tubular structures and outperform existing state-of-the-art methods. External validation on a private dataset also demonstrates good generalizability.
- 4 October 2024
- Published by Springer Nature
- p. 349-359
Improved Esophageal Varices Assessment from Non-contrast CT Scans
- 4 October 2024
- Published by Springer Nature
- p. 349-359
Improved Esophageal Varices Assessment from Non-contrast CT Scans
- Open Access
Improved Esophageal Varices Assessment from Non-Contrast CT Scans
Esophageal varices (EV), a serious health concern resulting from portal hypertension, are traditionally diagnosed through invasive endoscopic procedures. Despite non-contrast computed tomography (NC-CT) imaging being a less expensive and non-invasive imaging modality, it has yet to gain full acceptance as a primary clinical diagnostic tool for EV evaluation. To overcome existing diagnostic challenges, we present the Multi-Organ-cOhesion-Network (MOON), a novel framework enhancing the analysis of critical organ features in NC-CT scans for effective assessment of EV. Drawing inspiration from the thorough assessment practices of radiologists, MOON establishes a cohesive multiorgan analysis model that unifies the imaging features of the related organs of EV, namely esophagus, liver, and spleen. This integration significantly increases the diagnostic accuracy for EV. We have compiled an extensive NC-CT dataset of 1,255 patients diagnosed with EV, spanning three grades of severity. Each case is corroborated by endoscopic diagnostic results. The efficacy of MOON has been substantiated through a validation process involving multi-fold cross-validation on 1,010 cases and an independent test on 245 cases, exhibiting superior diagnostic performance compared to methods focusing solely on the esophagus (for classifying severe grade: AUC of 0.864 versus 0.803, and for moderate to severe grades: AUC of 0.832 versus 0.793). To our knowledge, MOON is the first work to incorporate a synchronized multi-organ NC-CT analysis for EV assessment, providing a more acceptable and minimally invasive alternative for patients compared to traditional endoscopy.
Open AccessImproved Esophageal Varices Assessment from Non-Contrast CT Scans
Esophageal varices (EV), a serious health concern resulting from portal hypertension, are traditionally diagnosed through invasive endoscopic procedures. Despite non-contrast computed tomography (NC-CT) imaging being a less expensive and non-invasive imaging modality, it has yet to gain full acceptance as a primary clinical diagnostic tool for EV evaluation. To overcome existing diagnostic challenges, we present the Multi-Organ-cOhesion-Network (MOON), a novel framework enhancing the analysis of critical organ features in NC-CT scans for effective assessment of EV. Drawing inspiration from the thorough assessment practices of radiologists, MOON establishes a cohesive multiorgan analysis model that unifies the imaging features of the related organs of EV, namely esophagus, liver, and spleen. This integration significantly increases the diagnostic accuracy for EV. We have compiled an extensive NC-CT dataset of 1,255 patients diagnosed with EV, spanning three grades of severity. Each case is corroborated by endoscopic diagnostic results. The efficacy of MOON has been substantiated through a validation process involving multi-fold cross-validation on 1,010 cases and an independent test on 245 cases, exhibiting superior diagnostic performance compared to methods focusing solely on the esophagus (for classifying severe grade: AUC of 0.864 versus 0.803, and for moderate to severe grades: AUC of 0.832 versus 0.793). To our knowledge, MOON is the first work to incorporate a synchronized multi-organ NC-CT analysis for EV assessment, providing a more acceptable and minimally invasive alternative for patients compared to traditional endoscopy.
- Open Access
Liver Tumor Screening and Diagnosis in CT with Pixel-Lesion-Patient Network
Liver tumor segmentation and classification are important tasks in computer aided diagnosis. We aim to address three problems: liver tumor screening and preliminary diagnosis in non-contrast computed tomography (CT), and differential diagnosis in dynamic contrast-enhanced CT. A novel framework named Pixel-Lesion-pAtient Network (PLAN) is proposed. It uses a mask transformer to jointly segment and classify each lesion with improved anchor queries and a foreground-enhanced sampling loss. It also has an image-wise classifier to effectively aggregate global information and predict patient-level diagnosis. A large-scale multi-phase dataset is collected containing 939 tumor patients and 810 normal subjects. 4010 tumor instances of eight types are extensively annotated. On the non-contrast tumor screening task, PLAN achieves 95% and 96% in patient-level sensitivity and specificity. On contrast-enhanced CT, our lesion-level detection precision, recall, and classification accuracy are 92%, 89%, and 86%, outperforming widely used CNN and transformers for lesion segmentation. We also conduct a reader study on a holdout set of 250 cases. PLAN is on par with a senior human radiologist, showing the clinical significance of our results.
Open AccessLiver Tumor Screening and Diagnosis in CT with Pixel-Lesion-Patient Network
Liver tumor segmentation and classification are important tasks in computer aided diagnosis. We aim to address three problems: liver tumor screening and preliminary diagnosis in non-contrast computed tomography (CT), and differential diagnosis in dynamic contrast-enhanced CT. A novel framework named Pixel-Lesion-pAtient Network (PLAN) is proposed. It uses a mask transformer to jointly segment and classify each lesion with improved anchor queries and a foreground-enhanced sampling loss. It also has an image-wise classifier to effectively aggregate global information and predict patient-level diagnosis. A large-scale multi-phase dataset is collected containing 939 tumor patients and 810 normal subjects. 4010 tumor instances of eight types are extensively annotated. On the non-contrast tumor screening task, PLAN achieves 95% and 96% in patient-level sensitivity and specificity. On contrast-enhanced CT, our lesion-level detection precision, recall, and classification accuracy are 92%, 89%, and 86%, outperforming widely used CNN and transformers for lesion segmentation. We also conduct a reader study on a holdout set of 250 cases. PLAN is on par with a senior human radiologist, showing the clinical significance of our results.
- 1 October 2023
- Published by Springer Nature
- p. 72-82
Liver Tumor Screening and Diagnosis in CT with Pixel-Lesion-Patient Network
- 1 October 2023
- Published by Springer Nature
- p. 72-82
Liver Tumor Screening and Diagnosis in CT with Pixel-Lesion-Patient Network
- Open Access
Anatomy-Aware Lymph Node Detection in Chest CT using Implicit Station Stratification
Finding abnormal lymph nodes in radiological images is highly important for various medical tasks such as cancer metastasis staging and radiotherapy planning. Lymph nodes (LNs) are small glands scattered throughout the body. They are grouped or defined to various LN stations according to their anatomical locations. The CT imaging appearance and context of LNs in different stations vary significantly, posing challenges for automated detection, especially for pathological LNs. Motivated by this observation, we propose a novel end-to-end framework to improve LN detection performance by leveraging their station information. We design a multi-head detector and make each head focus on differentiating the LN and non-LN structures of certain stations. Pseudo station labels are generated by an LN station classifier as a form of multi-task learning during training, so we do not need another explicit LN station prediction model during inference. Our algorithm is evaluated on 82 patients with lung cancer and 91 patients with esophageal cancer. The proposed implicit station stratification method improves the detection sensitivity of thoracic lymph nodes from 65.1% to 71.4% and from 80.3% to 85.5% at 2 false positives per patient on the two datasets, respectively, which significantly outperforms various existing state-of-the-art baseline techniques such as nnUNet, nnDetection and LENS.
Open AccessAnatomy-Aware Lymph Node Detection in Chest CT using Implicit Station Stratification
Finding abnormal lymph nodes in radiological images is highly important for various medical tasks such as cancer metastasis staging and radiotherapy planning. Lymph nodes (LNs) are small glands scattered throughout the body. They are grouped or defined to various LN stations according to their anatomical locations. The CT imaging appearance and context of LNs in different stations vary significantly, posing challenges for automated detection, especially for pathological LNs. Motivated by this observation, we propose a novel end-to-end framework to improve LN detection performance by leveraging their station information. We design a multi-head detector and make each head focus on differentiating the LN and non-LN structures of certain stations. Pseudo station labels are generated by an LN station classifier as a form of multi-task learning during training, so we do not need another explicit LN station prediction model during inference. Our algorithm is evaluated on 82 patients with lung cancer and 91 patients with esophageal cancer. The proposed implicit station stratification method improves the detection sensitivity of thoracic lymph nodes from 65.1% to 71.4% and from 80.3% to 85.5% at 2 false positives per patient on the two datasets, respectively, which significantly outperforms various existing state-of-the-art baseline techniques such as nnUNet, nnDetection and LENS.
- 1 January 2023
- Published by Springer Nature
- p. 299-310
Anatomy-Aware Lymph Node Detection in Chest CT Using Implicit Station Stratification
- 1 January 2023
- Published by Springer Nature
- p. 299-310
Anatomy-Aware Lymph Node Detection in Chest CT Using Implicit Station Stratification